Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer
Author:
Funder
AMIDEX
Les Laboratories Pierre Fabre
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00280-022-04455-x.pdf
Reference43 articles.
1. André N, Carré M, Pasquier E (2014) Metronomics: towards personalized chemotherapy? Nat Rev Clin Oncol 11:413–431
2. Barbolosi D, Ciccolini J, Lacarelle B, Barlesi F, André N (2016) Computational oncology–mathematical modelling of drug regimens for precision medicine. Nat Rev Clin Oncol 13:242–254
3. Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F (2014) Metronomics chemotherapy: time for computational decision support. Cancer Chemother Pharmacol 74:647–652
4. Briasoulis E, Pappas P, Puozzo C, Tolis C, Fountzilas G, Dafni U, Marselos M, Pavlidis N (2009) Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer. Clin Cancer Res 15:6454–6461
5. Rajdev L, Negassa A, Dai Q, Goldberg G, Miller K, Sparano JA (2011) Phase I trial of metronomic oral vinorelbine in patients with advanced cancer. Cancer Chemother Pharmacol 68:1119–1124
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vinorelbine administration impedes the timely progression of meiotic maturation and induces aneuploidy in mouse oocytes;Reproductive Toxicology;2024-09
2. Treatment of evolving cancers will require dynamic decision support;Annals of Oncology;2023-10
3. Mathematical Modeling Support for Lung Cancer Therapy—A Short Review;International Journal of Molecular Sciences;2023-09-25
4. Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial;Cancers;2022-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3